11 results
8-K
EX-1.1
KALV
KalVista Pharmaceuticals Inc
16 Feb 24
KalVista Pharmaceuticals Announces Pricing of a $160.1 Million Public Offering of Common Stock and Pre-Funded Warrants
4:32pm
, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including
8-K
EX-1.1
exvre7v86s li
11 Feb 21
KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of Common Stock
4:18pm
8-K
EX-1.1
m5ea0s ul9vaghdiurb
29 Mar 19
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-10.1
ptbofvuy42 z2nw2
2 May 18
Entry into a Material Definitive Agreement
12:00am
DRS
EX-10
qmkpce6como
19 Sep 14
Draft registration statement
12:00am
- Prev
- 1
- Next